Watch VNRX. Know when insiders buy.
One email the day a filing lands. Free.
VNRX
VOLITIONRX LTD
0.17
−0.00 −2.88%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.3MP/E —DIV YIELD —FCF YIELD -869.06%REV TTM $2.5M +86.3%NET INCOME −$25.6MNET DEBT $4.3M52W 0.17 – 9.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $399K | −2.0% | — | −$4.2M | −$7.3M | — | -0.85 | −$5.2M | $2K | −$5.2M | Aug 13 |
| Q1 2026 · Mar 31 | $985K | +299.8% | — | −$5.3M | −$6.7M | — | -0.97 | −$5.3M | $9K | −$5.3M | May 14 |
| Q4 2025 · Dec 31derived | $447K | +133.2% | — | −$4.8M | −$6.3M | — | — | −$5.5M | $11K | −$5.5M | Mar 31 |
| Q3 2025 · Sep 30 | $627K | +32.2% | — | −$5.1M | −$5.4M | — | -0.05 | −$3.6M | $0 | −$3.6M | Nov 13 |
| Q2 2025 · Jun 30 | $407K | +2.8% | — | −$6.3M | −$6.3M | — | -1.22 | −$6.3M | $77K | −$6.3M | Aug 13 |
| Q1 2025 · Mar 31 | $246K | +43.6% | — | −$5.5M | −$5.4M | — | -1.12 | −$4.3M | $2K | −$4.3M | May 14 |
| Q4 2024 · Dec 31derived | $192K | −21.4% | — | −$5.8M | −$5.8M | — | -0.06 | −$5.4M | $73K | −$5.5M | Mar 31 |
| Q3 2024 · Sep 30 | $475K | +187.2% | — | −$5.9M | −$5.8M | — | -0.07 | −$5.4M | $137K | −$5.5M | Nov 13 |
| Q2 2024 · Jun 30 | $396K | — | — | −$7M | −$7M | — | -0.08 | −$6.7M | $39K | −$6.8M | Aug 14 |
| Q1 2024 · Mar 31 | $172K | — | — | −$8.4M | −$8.4M | — | -0.10 | −$8.3M | $29K | −$8.4M | May 15 |
| Q4 2023 · Dec 31derived | $244K | — | — | −$8.7M | −$8.8M | — | — | $6.4M | $309K | $6.1M | Mar 31 |
| Q3 2023 · Sep 30 | $165K | — | — | −$8.7M | −$8.5M | — | — | −$8.4M | $273K | −$8.7M | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.7M | — | −$21.7M | −$23.4M | -1352.2% | — | −$19.7M | $90K | −$19.8M | — | — |
| FY2024 · to Dec 31 | $1.2M | — | −$27M | −$27M | -2186.3% | -0.31 | −$25.9M | $277K | −$26.2M | $0 | — |
| FY2023 · to Dec 31 | $775K | — | −$36M | −$35.7M | -4601.7% | -0.50 | −$18.1M | $1.1M | −$19.1M | $32K | — |
| FY2022 · to Dec 31 | $306K | — | −$31.8M | −$30.6M | -9986.7% | — | −$15.3M | $1.6M | −$16.8M | $0 | — |
| FY2021 · to Dec 31 | $90K | — | −$28.3M | −$27M | -29977.0% | -0.51 | −$20.9M | $974K | −$21.8M | — | — |
| FY2020 · to Dec 31 | $13K | — | −$21.2M | −$20.4M | -151859.6% | -0.45 | −$16.5M | $1.9M | −$18.4M | — | — |
Every number comes from VOLITIONRX LTD's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.